Zoi SAS

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Zoi SAS - overview

Established

2021

Location

Paris, -, France

Primary Industry

Healthcare

About

Based in Paris, France, and founded in 2021, Zoi SAS is a personalized preventive medicine application that combines routine medical checkups with preventive care. The company was co-founded by Ismaël Emelien (CEO), former special advisor to Emmanuel Macron, and Paul Dupuy. The team also includes Cédric Carbone(CTO), Fabrice Bonan (CPO), and Dr. Claude Dalle (CSA).


In January 2022, Zoi SAS raised USD 23 million in seed funding led by individual investors including Stéphane Bancel (CEO of Moderna) and Jean-Claude Marian (founder of Orpea, a leading European healthcare real-estate company) among others. Zoi offers routine medical checkups focusing on preventive care through a mobile app. The company combines data science with behavioral sciences by the mean of a deep-tech proprietary system that starts with a 360° physical check-up, blood samples, vision, hearing, and heart checks, and much more. Then Zoī provides patients with personalized and actionable insights, giving them the keys to drastically improving their quality of life.


Zoi SAS plans to use the 2022 funding to complete the company's team, which already has some well-recognized specialists in their respective fields. It will also open physical health centers in Spring 2023.


Primary Industry

Healthcare

Sub Industries

Healthcare, Healthcare IT

Website

www.zoi.com

Verticals

HealthTech

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.